ArticleVaccines2021

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.

Paul E Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.